From 2013 to 2023, France's antisera market size per capita grew from $159.95 to $255.64, showing significant annual variations. In the past two years, the market experienced a year-on-year increase of 2.79% in 2022 followed by 2.78% in 2023. Over the last five years, the market exhibited a compound annual growth rate (CAGR) of approximately 2.80%, indicating a steady rise in demand and expenditure for antisera products.
Looking forward, future trends include a focus on personalized medicines that may boost the demand for antisera, technological advancements in antibody production, and the expansion of global health initiatives to curb infectious diseases, which would further propel the market's growth.
